Drug factory · FDA FEI 3014615000
SMS Pharmaceuticals limited
Central Laboratory Analytical Services Building No 2, First Floor Survey No 186 189 190, Gagillapur (V), Medchal-Malkajgiri, Hyderabad, India
No problems found at FDA's last inspection, Jun 25, 2025.
No Action Indicated: inspectors found no objectionable conditions.
2 drug inspections on record since 2020: 2 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Macitentan and Tadalafil | Tests it | Actelion Pharmaceuticals US, Inc. | 66215-812, 66215-814 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jun 25, 2025 | No problems found | Drug Quality Assurance | — |
| Mar 5, 2020 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis.